Jun 30, 2019

Cogent Biosciences Q2 2019 Earnings Report

Total Revenue
$3.14M
Previous year: $1.67M
+88.4%
EPS
-$0.34
Previous year: -$0.31
+9.7%
Gross Profit
-$7.48M
Previous year: $1.67M
-548.9%
Cash and Equivalents
$55.9M
Previous year: $46.7M
+19.5%
Free Cash Flow
-$11.3M
Previous year: -$8.3M
+36.7%
Total Assets
$69.3M
Previous year: $103M
-32.5%

Cogent Biosciences

Cogent Biosciences